WHO Cambodia is inviting applications for a Short Term Consultancy (STC) to provide technical support to National Center for Tuberculosis and Leprosy Control in Cambodia Short Term Consultancy (STC)The World Health Organization (WHO) would like to recruit an experienced and dynamic consultant to provide technical support to National Center for Tuberculosis and Leprosy Control in Cambodia. During working period consultant work closely Team Leader of Communicable Disease, country office, Coordinator End TB and Leprosy Unit Division of Communicable Diseases World Health Organization, Regional Office for the Western Pacific, and National Center for TB and Leprosy Control to achieve the following expected outputs. The recruited consultant will work for 6 months (01 Dec 2018-31 May 2019) with possible extension and the duty station is in Phnom Penh, Cambodia. Locations: World Health Organization (WHO) and National Center for TB and Leprosy Control (CENAT). Deadline for applications: 26 October 2018 1. Background Progress made by Cambodia’s National TB program has been significant. The incidence rate of TB all forms has fallen from 575 per 100,000 populations in year 2000 to 345 per 100,000 pop in 2016, which equal to 40% reduction. TB mortality rate dropped from 42 per 100,000 populations in year 2000 to 20 per 100,000 populations in year 2016, which equal to 52% reduction. However, Cambodia remains one among 30 countries with high burden of tuberculosis in the world. TB cases notification were 34, 467 among estimated incident 52,000 cases in 2017. There are gaps 34% of missing cases not yet identified. There were estimated 1.8% of TB cases with Multidrug-/rifampicin Resistant (MDR /RR-TB) mong new cases and 11% among previously treated cases. Treatment coverage is 66% with the 94% success rate among new and relapse cases (cases registered in 2016) and 71% among MDR/RR-TB cases (cases registered in 2015). TB preventive treatment among child (aged < 5 years) household contacts of bacteriology confirmed is 44% in 2017. National TB program had been committed to response TB issues, with support from the Global Fund and USAID, local and International NGOs had been working to contribute to the national TB response including maintaining and expanding TB prevention, routine/active case findings, TB children, MDR TB and Treatment of latent TB infection. To reach End TB goal, there is need to continue effort to fill the gaps through scaling up high quality integrated patient-centered TB care and prevention including strengthening early diagnosis of tuberculosis with better use of diagnostic algorithm and technology and are implemented through systemic contact screening, routine case findings, hospital linkage and semi or active case finding among high-risk groups, and early access to treatment and care. Effort are needed on strengthening programmatic management of drug- resistance TB including early Drug - Resistant TB detection, access of universal drug susceptibility testing and increasing uptake innovations ; including new drugs and novel regiment. There is necessity to keep updating treatment guidelines per latest WHO recommendation for treatment of MDR and Latent TB infection, maintaining good treatment success rate for new and relapse and improving more treatment success among Drug resistant TB. Assessment of intervention and program review are crucial to review the success, lessons learned, bottle necks to better prepare for more effective and innovative approaches. In addition, intensifying research and innovation to promote the use of new diagnostic tool, interventions, strategies to generate evidence for policy formulation and implementation are also important. The WHO consultant should, therefore, engage with government and non-state actors at all levels for evidence generation and evidence based decision, policy formulation, and implementation monitoring and evaluation. In addition to the following expected outcomes, the consultant are expected to perform other related duty as required and works with National Center for Tuberculosis and Leprosy Control (CENAT) and non-state actors in the implementation of the National Strategic Plan for Control of TB 2014-2020. 2. Planned timelines (subject to confirmation) Start date: 1 December 2018_End date: 31 May 2019 3. Work to be performed • Description of activities to be carried out: Collaborates with the Team Leader of Communicable Disease/ National Program Officer in Country office, WHO Head Quarter and Western Pacific Region (WPRO), National Center for TB and Leprosy Control (CENAT) and key stake holders, consultant will: I- Facilitate WPRO and CENAT to conduct Joint TB program Review for Cambodia and provide technical support to implement the findings; II- Provide technical support to generate national action plan based on the result from the Drug Resistance Survey; III- Develop national operational research priority agenda and national research protocol; IV- Assessment of current TB case finding interventions; V- Update the current national treatment guidelines/ SOP, training material based on the update of WHO guidelines ( end of 2018) VI- Technical support for functioning Latent TB Infection( LTBI) task force/ working group and implementation of shorten 3 month- regimen of isoniazid and rifapentine (3HP) for treatment of LTBI VIII- Work with CENAT to Develop childhood TB diagnosed approaches to improve TB case finding and national up take of new child friendly formula to promote and scale up of better TB treatment in children • Method(s) to carry out the activity • Output/s • Output 1: Joint TB program Review, provide technical support to revise national strategic plan for TB control and provide technical support to implement the findings • Deliverable 1.1: Facilitate with TB coordinator of WHO Western Pacific Region (WPRO)/Head Quarter and CENAT for preparation, conducting and reporting of the Joint TB program Review for Cambodia. Consultant will actively participate in developing agenda, technical and administrative arrangement of the joint team per focussed thematic areas of the program review, and take part in the review team and report. She/he will continue providing technical support to CENAT for the implementation of the findings. • Deliverable 1.2: Provide technical support to CENAT to revise the national strategic plan for control of TB 2014-2020, through a wide consultation with relevant key stake holders and donors in consideration of each thematic findings and reflecting current and future health system approach including but not limited to health financing, quality improvement, and human resource strategy. • Output 2: Generated action plan and implementation technical support based on the result from the National Drug Resistance Survey; • Deliverable 2.1: Take lead to coordinate with CENAT, stake holders and in technical consultation with WPRO team to generate action plan based on the findings from National Drug Resistance Survey. • Deliverable 2.1: Provide effective technical support to CNEAT and stake holders in implementation the action plan to improve national drug resistant management including diagnosis tool and treatment guidance/regiment and any initiative. • Output 3: report of national operational research priority agenda and national research protocol; • Deliverable 3.1: Consult with WPRO team, and take lead to work with CENAT and key stake holder to held technical working group in developing national operational research priority agenda and national research protocol. • Output 4: Assessment of current TB case finding interventions • Deliverable 4.1: Work with CENAT, key implementers to understand current different interventions of TB case findings supported by Global Fund and from USAID fund which include TB screening at pagodas for elderly populations, systematic screening for prison inmates, household screening for contacts of infectious cases, and screening for people living HIV and with diabetes. • Deliverable 4.2: Discuss with WPRO team, CENAT and key stake holders to mobilize the technical and funding resources to conduct the effectiveness and efficiency of these interventions in Cambodia to develop recommendations for scaling such approaches. • Output 5: Updated national treatment guidelines/ SOP and updated training materials following the new update of WHO treatment guidelines (end of 2018). • Deliverable 5.1: In consultation with WPRO, facilitate with CENAT and key stake holders to update the current national TB treatment guidelines/SOP following the WHO updated treatment guidelines which is expected by the end of 2018. • Deliverable 5.2: Participate in clinical monitoring visit with CENAT/stake holder on USAID and Global Fund implementing sites at operational district, referral hospital and Health Centre levels to identify issues and provide recommendation for improving quality of TB diagnosis and treatment. • Deliverable 5.3: Work with CENAT and key stake holders to update training materials for physicians. • Output 6: Functioning LTBI task force/ working group and implementation of shorten 3 month- regimen of isoniazid and rifapentine (3HP) for treatment of LTBI • Deliverable 6.1: Manage the implementation of WHO Communicable Disease Cluster Enabler Grant supported by UNITAID through closely cooperate with and technical support CENAT and Key implement partners to ensure the functioning of LTBI task force/working group and implement latest WHO’s recommendation of shorten 3 month- regimen of isoniazid and rifapentine (3HP) for treatment of LTBI. • Output 7: Developed childhood TB diagnosed approaches to improved TB case finding and national up take of new child friendly formula to promote and scale up of better TB treatment in children • Deliverable 7.1: Manage the implementation of WHO Communicable Disease Cluster Enabler Grant supported by UNITAID through closely cooperate with and provide technical support to CENAT to update childhood TB diagnosed approaches/tool to improved TB case finding and ensure national up take of new child friendly formula per WHO latest recommendation 4. Specific requirements - Qualifications required: Education (qualification): • Essential: University degree in medicine from a recognized institution and post-graduate degree in public health. Training in tuberculosis programmes. • Desirable: Managerial training and training in clinical or TB epidemiology research. Experience: • Essential: Minimum of 7 years of experience in public health, including experience in tuberculosis control programme. • Desirable: Work experience in public health in developing countries, experience in planning, developing and evaluating tuberculosis programmes. - Language requirements: Fluent written/spoken English 5. Competencies 1. Communicating in a credible and effective way 2. Producing results 3. Moving forward in a changing environment 4. Fostering integration and teamwork Building and promoting partnerships across the organization and beyond Interested applicants are required to send proposal and CV to the WHO Office through e-mail: [email protected] Smoking is not allowed in WHO premises. The mission of WHO is the attainment by all peoples of the highest possible level of health. For additional information please contact the WHO office in Phnom Penh located at 1st floor,No. 61-64,Preah Norodom Blvd, (corner street 306),Sangkat Boeung Keng Kang I, Khan CHamkamoun, Phnom Penh., by email under [email protected] telephone under (023)216610.